Delivery Order SPE2DB22D3501-SPE2DB25FUC40
Award Date
1/10/25
Potential Completion Date
1/13/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,590.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMICADE 100 mg vials, a specialty medication. This is a firm fixed-price delivery order contract with a period of performance through January 7, 2025. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen...
This federal contract award, valued at $3,206.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Remicade 100 mg vials, a specialty medication used in the treatment of various medical conditions.
The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,756.96, is a delivery order for the supply of Remicade 100 mg vials. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This federal contract award, valued at $26,900.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMICADE 100 MG VIALS, a specialty medication, with a completion date of January 7, 2025.
The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of REMICADE 100 MG VIALS. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $6,813.32. The contract has an ultimate completion date of December 4, 2024.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $19,018.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of REMICADE 100 MG VIALS, a specialty pharmaceutical product.
The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of REMICADE 100 MG VIALS. The $75,150.30 delivery order contract is a firm fixed-price arrangement with an ultimate completion date of September 16, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,972.80 firm fixed-price delivery order is for the supply of Remicade 100 mg vials, a specialty medication. The contract has an ultimate completion date of December 16, 2024 and was awarded on December 13, 2024.
This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The award, valued at $24,182.96, is for the delivery of REMICADE 100 MG VIALS, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 16, 2024.
AmerisourceBergen, a major pharmaceutical distribution company, holds two Indefinite Delivery Contracts (IDCs) with the DLA and...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,086.00 firm fixed-price delivery order is for the supply of 100 mg vials of the medication Remicade. The award was made under a broader Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through December 2025. This IDC serves as the...